SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-253519
Filing Date
2023-10-10
Accepted
2023-10-10 16:40:29
Documents
14
Period of Report
2023-10-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d555586d8k.htm   iXBRL 8-K 28997
2 EX-1.1 d555586dex11.htm EX-1.1 193542
3 EX-5.1 d555586dex51.htm EX-5.1 7719
  Complete submission text file 0001193125-23-253519.txt   414101

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA iron-20231010.xsd EX-101.SCH 2867
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE iron-20231010_lab.xml EX-101.LAB 18739
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iron-20231010_pre.xml EX-101.PRE 11719
8 EXTRACTED XBRL INSTANCE DOCUMENT d555586d8k_htm.xml XML 3481
Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39438 | Film No.: 231318450
SIC: 2834 Pharmaceutical Preparations